Sterne Kessler Goldstein Fox

Stem cell research holds the promise of the prevention, diagnosis and treament of a variety of conditions including Alzheimer's, Parkinson's, cancer, diabetes and spinal cord injuries to name a few. 

In keeping with our tradition of providing intellectual property counsel to those working in leading edge technologies, in 2004, our firm formed a Stem Cell Task Force. The Task Force, which is staffed by firm members with experience in the IP of stem cells, is staying abreast of legal and policy developments, and has defined, as its principal mission, to keep you informed and up to date in this exciting field.